Cardiovascular monitoring of children and adolescents receiving psychotropic drugs: A statement for healthcare professionals from the Committee on Congenital Cardiac Defects, Council on Cardiovascular Disease in the Young, American Heart Association

Circulation. 1999 Feb 23;99(7):979-82. doi: 10.1161/01.cir.99.7.979.
No abstract available

Publication types

  • Guideline
  • Practice Guideline

MeSH terms

  • Adolescent
  • Cardiovascular System / drug effects*
  • Child
  • Drug Interactions
  • Electrocardiography / drug effects
  • Heart Conduction System / drug effects
  • Humans
  • Monitoring, Physiologic*
  • Psychotropic Drugs / adverse effects*
  • Psychotropic Drugs / therapeutic use

Substances

  • Psychotropic Drugs